Pneumococcal Conjugate Vaccine for Adults: A New Paradigm

In R&D by Freya SmaleLeave a Comment

download, pfizer, Pneumococcal conjugate vaccine, World Vaccine Congress 2013

 

In April 2013 over 500 delegates participated in the 13th Annual World Vaccine Congress Washington. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by William Gruber, Pfizer entitled: ‘Pneumococcal Conjugate Vaccine for Adults: A New Paradigm'

This presentation outlines:

  • Efficacy of PPSV23
  • Limitations of Polysaccharide Vaccine
  • Free Polysaccharide Vaccine Immunobiology T-Cell Independent Response
  • Advantages of Polysaccharide Conjugate Vaccine
  • Polysaccharide Conjugate Vaccine Immunobiology T-Cell Dependent Response
  • Conjugate Vaccine Efficacy Against Pneumococcal Disease in Children
  • Efficacy of PCV7 and PPSV23 in HIV Infected Adults
  • Goals of the PCV13 Adult Phase 3 Program
  • Functional Antibody is Targeted Against Capsule Polysaccharide (CPS)
  • Measure of Anti-Pneumococcal Immunity
  • Direct Comparison of Responses to PCV13 and PPSV23 

Download the full presentation here >

For more information about this and other topics discussed at the World Vaccine Congress Washington, subscribe to the Vaccine Nation newsletter, or visit the event website.

Leave a Comment

Current ye@r *